Movement Disorders Drugs

Random Miscellaneous Quiz

Can you name the Movement Disorders Drugs?

Quiz not verified by Sporcle

How to Play
Challenge
Share
Tweet
Embed
HintAnswer
Pergolide class
Olanzapine class
Phenothiazine class
P-kinetics: Start with a small dose
Interactions: Should not be taken w/ meperidine, TCAs, serotonin reuptake inhibitors, or in combo w/ nonspecific MAOIs
P-kinetics: Only helpful for Huntington's dz chorea at very high doses
Use: Can be used as 1st line tx for Parkinson's dz - often in combo w/ Sinemet. Commonly used to tx hyperprolactinemia.
Haloperidol class
Benzotropine class
MOA: Somewhat selective MAO-B inhibitors. Retard the breakdown of dopamine
MOA: Increases dopamine release & reduces dopamine reuptake into dopaminergic nerve terminals of substantia nigra neurons. Unknown MOA.
Tolcapone class
Apomorphine class
Use: May improve tremor & rigidity in Parkinsons. Little effect on bradykinesia.
P-kinetics: Response can decline over time or stop completely. Start at small dose & escalate as effects diminish. Wearing off rxs. Toxicity concern is supersensitivity develpmnt -
SE: If adverse effects become too severe withdraw gradually. break for 3-21 days, and reinstate gradually
P-kinetics: Well absorbed orally. T1/2 ~ 12 hrs. Hepatic metabolism (cytochrome P450, CYP1A2) -- caution in pts w/ hepatic insufficiency.
Use: Most effective drug in tx of Tourette's
Use: alleviation of chorea if refractory to atypical
P-kinetics: 2/3 appears in urine as metabolites within 8 hrs (homovanillic acid - HVA and dihydrocyphenylacetic acid - DOPAC). Best response is in the first few yrs of tx.
Clonazepam class
Contraindications: Prostatic hyperplasia, obstructive GI dz, & angle-closure glaucoma
Procyclidine class
SE: GI (L-dopa alone): anorexia, n/v (avoid anti-emetics like phenothiazines d/t their extrapyramidal effects -- dopamine antagonist; carbidopa reduces these effects.
P-kinetics: SQ. Rapid onset ~ 10 min. Duration 2 hrs
SE: Ergoline-induced toxicity effects unlikely. Postural hypotension, fatigue, somnolence, peripheral edema, nausea, constipation, dyskinesias, & confusion.
Use: Similar to Bromocriptine, but more effective. May benefit pts not receiving L-dopa. Aids pt w/ response fluctuations to L-dopa
Risperidone class
Selegiline class
Use: alleviation of chorea
Amantadine class
MOA: Inhibits the L-dopa --> dopamine conversion by dopa decarboxylase in the periphery (does not cross BBB).
HintAnswer
Butyrophenones class
Pramipexole class
P-kinetics: Readily absorbed from intestines (depends on rate of gastric emptying and pH -- delayed by food). Some other AAs can compete for transport across the BBB.
P-kinetics: Start at low dose & gradually increase
Carbamazepine class
Carbidopa class
SE: Dyskinesias: chorea, ballismus, athetosis, dystonia, myoclonus, tics, tremors. Behavioral effects: anxiety/ agitation, insomnia/ somnolence, confusion/ delusions/ hallucination
Biperiden class
Trihexyphenidyl class
MOA: Central (brain) anti-cholinergic
Use: Enhance & prolong the effects of L-dopa; reduce response fluctuations; lowers necessary dose of L-dopa. ?Antioxidant properties?
P-kinetics: Given PO. Loses effectiveness over time.
P-kinetics: Variable absorption from GI, peak plasma levels 1-2 hrs post PO dose. Excreted in bile & feces. Build up dose slowly over 2-3 mo to avoid adverse effects
MOA: Prevents the metabolism of L-dopa --> 3-O-methyldopa (3OMD) by Catechol-0-methyltransferase
Fluphenzaine class
Tetrabenxine class
Riluzole class
Group P-kinetics: Advantages: No enzymatic conversion required, crosses BBB w/o competing for amino acid transporter. No potentially toxic metabolites
SE: Other: dry mouth, blurred vision, mydriasis, urinary retention, n/v, constipation, tachycardia, increased IOP.
Use: Huntington's dz pts w/ psychosis or disruptive behavior. Also helpful w/ chorea
Use: Reduced response to fluctuations w/ L-dopa. Decreased L-dopa clearance. Decreased dopa decarboxylase --> compensatory increase in COMT.
MOA: Preferential affinity for D3 family of receptors
Bromocriptine class
P-kinetics: Similar to Pramipexole
Carbidopa + levidopa (1:10 or 1:4)
Quetiapine class
Clonidine class
SSRI class
Use: Increases amount of L-dopa able to cross the BBB. Combo with L-dopa allows for L-dopa dose reduction up to 85%.
MOA: D2 receptor agonist (partial D1 agonist)
Use: Temporary relief of off-period akinesia in Parkinsons. Also used to tx ED.
Use: Similar to Pramipexole
HintAnswer
TCA class
Contraindications: psychotic pts, angle closure glaucoma (Increased IOP), active peptic ulcers, hx of melanoma (melanin precursor)
P-kinetics: Rapid PO absorption, excreted unchanged in urine, gradually increase dose
SE: May interfere with uptake - Rx metabolizes L-dopa into 3-methyldopa which competes for active transport across the BBB.
SE: Insomnia when taken late in the day
P-kinetics: Only 1-3% enters the brain across BBB unaltered. Peak plasma levels 1-2 hrs post PO dose. Plasma t1/2 = 1-2 hrs (pts vary -- dosing 3-4x/day).
Use: Monotherapy for mild Parkinsonism or combo tx for advanced pts. Reduces L-dopa dose & smooths response fluctuations. Putative neuroprotective effects (scavenges free radicals)
Use: prolong ALS survival by months
Ropinirole class
Contraindications: psychotic illness, MI hx, PVD, peptic ulcers
Reserpine class
SE: CV: Increased HR, PVCs, A fib (rare), postural hypotension, HTN (usually in the presence of non-specific MAOI or with large doses).
SE: Mental Disturbances: confusion, hallucinations, delusions, other psychiatric reactions.
P-kinetics: Note: Antidepressant MAOIs are either nonspecific or inhibit MAO-A more specifically (5-HT & NE)
MOA: Dopamine precursor able to cross the BBB where it is decarboxylated by dopa decarboxylase to form dopamine.
Use: Gold standard in Parkinson's dz - most efficacious treatment
Orphenadrine class
Entacapone class
SE: Nausea (pretreat w/ anti-emetic - trimethobenzamide or domiperidone), dyskinesias, drowsiness, sweating, hypotension
SE: Asthenia, dizziness, GI disorders, & elevation of liver enzymes.
SE: HA, nasal congestion, increased arousal, pulmonary infiltrates, ergoline-induced s/s, erythromelagia, vasospasm, & pleural or retroperitoneal fibroses.
MOA: Pure D2 receptor agonist
SE: Increased L-dopa toxicity (dyskinesias, nausea, & confusion), diarrhea, abd pain, orthostatic hypotension, sleep disturbances, & orange urine.
Rasagiline class
MOA: Not completely known. Inhib effects on glutamate-R, NMDA antag, Inactivation of voltage gated Na+ channels. Interferes w/ intracellular events post excitatory AA-R activation
Use: depression associated with Huntington's disease
SE: CNS: drowsiness, mental slowness, inattention, restless, confusion, agitation, delusions, hallucinations, & mood changes.
Interactions: Vitamin B6 enhances the extracerebral metabolism of L-dopa. MAOI w/ L-dopa can --> HTNive crisis if given within 2 weeks of each other.
SE: GI: anorexia, n/v, constipation, dyspepsia, peptic ulcers, symptoms of reflux esophagitis. CV: postural hypotension & cardiac arrhythmias. Dyskinesias.
MOA: D1 and D2 receptor agonist
Levodopa class
SE: May be hepatotoxic - (needs signed pt consent & liver monitoring Q 2 wks x 1 yr)

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras


Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.